TAS delivers a record-breaking year of life-saving care

The end of year report for 2024 to 2025 is now available

29 August 2025

Therapeutic Apheresis Services (TAS) has achieved remarkable milestones in 2024 to 2025, delivering more lifesaving treatments than ever before while maintaining exceptional patient satisfaction. 

Read the end of year report for 2024 to 2025

Record service delivery

TAS completed 13,091 procedures this year. This is a 5% increase from the previous year and the highest number in our history. Our teams supported 2,376 patients and 257 registry donors across England and Wales, operating 24 hours a day, 365 days a year from 8 regional centres. 

Expanding access to care

We established 10 new services to bring expert care closer to patients' homes. Notable achievements include launching a 24/7 automated red cell exchange service in collaboration with South Tees Hospital NHS Foundation Trust. We also introduced a new stem cell collection service in the Midlands, reducing travel burdens for patients requiring these specialist treatments. 

Clinical excellence and innovation

Our commitment to advancing healthcare saw us support 19 clinical trials, contributing to the development of new therapies.

We successfully collaborated with Royal Manchester Children's Hospital and Vertex to support CASGEVY, a groundbreaking gene-editing treatment for beta-thalassaemia and sickle cell disorder.

Ultrasound-guided cannulation continues to transform patient experience, saving over 200 central line procedures and reducing treatment delays whilst minimising patient discomfort. 

Outstanding patient satisfaction

Patient feedback remains exceptional, with 96% of survey respondents scoring TAS 9 or 10 out of 10 for overall satisfaction. This is an increase of 18% in response rates from the previous year.

We received 305 compliments compared to just 4 complaints, with patients consistently praising our staff's professionalism, knowledge and compassionate care. 

Looking forward

With significant investment in our workforce and the upcoming launch of TAS Connect – our new digital platform, we're well positioned to continue expanding services and improving patient outcomes in 2025 to 2026. 

Teresa Baines, Nursing Head of TAS and Deputy Chief Nurse for Clinical Services said: 

“As I look back on last year, I remain immensely proud of my dedicated team and of the contribution made by every single one of them. Each role in TAS has played a vital part and made a huge difference to the patients and donors we serve.”

Teresa Baines - Nursing Head of Therapeutic Apheresis Services